Universitat de Barcelona - Hospital Sant Joan de Deu Barcelona (HSJDB)

Esplugues de Llobregat, Barcelona 8950

1 studies enrolling now · 1 studies all time

What they study most

Autosomal Recessive Polycystic Kidney (ARPKD)

Studies at this site

• A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) — Recruiting now